Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole vs lansoprazole for upper gastrointestinal bleeding
CTR20192683Phase 3Completed
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexlansoprazole in upper gastrointestinal bleeding (UGIB), gastric ulcer, duodenal ulcer, sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Dec 2019; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on CTR20192683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192683.